New approach aims to make starting opioid addiction treatment easier

NCT ID NCT07439549

Recruiting now Disease control Sponsor: Pouya Azar Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new approach called SINI to help people with opioid use disorder start buprenorphine treatment more comfortably. Participants receive small doses of naloxone to trigger mild withdrawal, then take buprenorphine to ease symptoms, followed by a long-acting injection. The goal is to see if this method is safe and practical in both hospital and outpatient settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID USE DISORDER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hope to Health Research & Innovation Centre
NOT_YET_RECRUITING

Vancouver, British Columbia, V6A 1H2, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Vancouver General Hospital
RECRUITING

Vancouver, British Columbia, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact